SCHEMBL7799262

SCHEMBL7799262

CCC(=O)NC(CSSCC(NC(=O)CC)C(=O)NCCc1ccccc1)C(=O)NCCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.52
MTNR1A P48039 1/20 0.51
MTNR1B P49286 1/20 0.51
ITGB3 P05106 1/20 0.48
ITGA2B P08514 1/20 0.48
ANPEP P15144 1/20 0.47
KMT2A Q03164 2/20 0.47
MEN1 O00255 1/20 0.47
TSHR P16473 1/20 0.47
CA12 O43570 1/20 0.47
CA2 P00918 1/20 0.47
CA9 Q16790 1/20 0.47
MMP8 P22894 2/20 0.46
CHRNB2 P17787 1/20 0.46
CHRNB4 P30926 1/20 0.46
CHRNA3 P32297 1/20 0.46
CHRNA4 P43681 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7802323 0.87 ITGB3 (0.54) ITGB3ITGA2BCHRNB2CHRNB4CHRNA3
SCHEMBL7793435 0.86 CA12 (0.52) POLBANPEPKMT2AMEN1TSHR
SCHEMBL7793390 0.83 KMT2A (0.57) KMT2ACA12CA2CA9
SCHEMBL7799269 0.82 MTNR1A (0.45) POLBMTNR1AMTNR1BITGB3ITGA2B
SCHEMBL7803203 0.81 POLB (0.51) POLBANPEPKMT2AMEN1TSHR
SCHEMBL7798889 0.80 NPC1 (0.64) POLBKMT2AMMP8
SCHEMBL7793406 0.79 POLB (0.49) POLBANPEPKMT2AMEN1TSHR
SCHEMBL7798914 0.78 POLB (0.48) POLBKMT2ACA12CA2CA9
SCHEMBL23154579 0.78 LMNA (0.56) ANPEPKMT2AMMP8CHRNB2CHRNB4
SCHEMBL7799255 0.78 L3MBTL1 (0.50) KMT2ACYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1143960-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES Roche Diagnostics GmbH (DE) 2001-10-17 EP disclosed
WO-2000027378-A2 CYSTINE DERIVATIVES AS THERAPEUTIC AGENTS FOR MATRIX METALLOPROTEASE RELATED DISEASES ROCHE DIAGNOSTICS GMBH (DE) 2000-05-18 WO disclosed